Pasar al contenido principal

DINAMICA DE LA MEMBRANA MITOCONDRIAL Y SUS SITIOS DE CONTACTO ENTRE ORGANULOS EN LA FISIOPATOLOGIA CELULAR Y DEL NERVIO DE LA ENFERMEDAD NEUROGENETICA

PID2020-114655RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO PER A LA RECERCA I LA DOCENCIA SANT JOAN DE DEU (FSJD)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot-Marie-Tooth Disease

  • Estévez-Arias, Berta
  • Sarv, Siiri
  • Bonello-Palot, Nathalie
  • Carrera-Garcia, Laura
  • Ortez, Carlos
  • Expósito-Escudero, Jesica
  • Yubero, Delia
  • Muchart, Jordi
  • Delmont, Emilien
  • Oiglane-Shlik, Eve
  • Meren, Teele
  • Puusepp, Sanna
  • Murumets, Ülle
  • Salomons, Gajja S.
  • Udd, Bjarne
  • Väli, Liis
  • Cantarero, Lara
  • Bönnemann, Carsten G.
  • Nascimento, Andrés
  • Ramón-Maiques, Santiago
  • Õunap, Katrin
  • Hoenicka, Janet
  • Natera-de Benito, Daniel
  • Palau, Francesc
17 páginas, 5 figuras, 2 tablas, Objective: Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of genetic neuropathies, with >90 genes identified. Several aminoacyl-tRNA synthetases have been linked to CMT. DARS2, encoding the mitochondrial aspartyl-tRNA synthetase, has been typically associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation. This study aimed to investigate the association between biallelic DARS2 variants and axonal CMT. Methods: We investigated 5 individuals from 3 unrelated families with axonal CMT and biallelic DARS2 variants. Functional studies in fibroblasts assessed their effects on DARS2 expression, localization, and mitochondrial function. Enzymatic activity was evaluated in HEK293 cells. Results: The 5 individuals, including 4 adults, presented with childhood-onset progressive axonal CMT. None had leukoencephalopathy, but one showed central nervous system involvement, with intellectual disability and epilepsy. Genetic analysis identified compound heterozygous DARS2 variants: family A, p.Ser238Phe and p.Arg336Cys; family B, p.Ser238Phe and p.Ile25Thrfs*38; family C, c.492+2T>C and p.Pro503Leu. Functional studies revealed reduced DARS2 protein levels, mitochondrial network abnormalities, and impaired mitochondrial function. p.Ser238Phe behaves as a hypomorphic allele, whereas p.Pro503Leu reduced DARS2 enzymatic activity by 75%. Interpretation: Our findings expand the DARS2-related disease spectrum, establishing a novel association with axonal CMT. Hypomorphic variants, such as p.Ser238Phe, when paired with more deleterious variants, result in isolated axonal CMT, whereas more severe combinations-although not as deleterious as those seen in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation-result in axonal CMT with central nervous system involvement, albeit without leukoencephalopathy. These observations raise the possibility that DARS2-associated diseases form a continuum rather than representing strictly distinct central or peripheral nervous system disorders., B.E.A. was supported by the predoctoral program “Joan Oró” of the Secretary of Universities and Research of the Department of Research and Universities of the Government of Catalonia with code 2025 FI-2 00075, cofinanced by the European Union. D.NdB. was supported by the Miguel Servet program from Instituto de Salud Carlos III, Spain (CP22/00141). The FP research group is funded by the Spanish Research Agency (AEI) grant PID2020-114655RB-I00, the European Union’s Horizon Europe research and innovation program under grant agreement No 101136262, and the AGAUR, Generalitat de Catalunya, grant 2021-SGR-01610. S.S. and K.Õ. are supported by the Estonian Research Council grants PRG471 and PRG2040, and funding IDOLS-G from Estonian Social Ministry as a part of the European Joint Program on Rare Diseases (EJP-RD). S.R-M. is supported by grant PID2021-128468NB-I00 financed by MCIN/AEI/10.13039/501100011033 and by grant from Funcaci on Ram on Areces Ciencias de la Vida, CC National call. B.E.A., C.O., C.J., J.E.E., L.C.G., A.N., L.V., and D.NdB. are members of the European Reference Network for Neuromuscular Diseases ERN-NMD – Project ID No. 870177. F.P. and K.Õ. are members of the ERN-ITHACA on Rare Malformations Syndromes, Intellectual and Other Neurodevelopmental Disorders, Peer reviewed